When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SYN - Synthetic Bio inks deal to advance development of candidate SYN-020
Synthetic Biologics Inc.
Synthetic Biologics (NYSEMKT:SYN) has entered into an agreement with Massachusetts General Hospital (MGH), granting the company an option for an exclusive license to intellectual property and technology for the use of intestinal alkaline phosphatase to maintain GI and microbiome health, diminish systemic inflammation and treat age-related disorders. The company intends to use the license to advance SYN-020, a recombinant bovine intestinal alkaline phosphatase to treat and prevent metabolic and inflammatory diseases associated with aging.
More news on: Synthetic Biologics, Inc., Healthcare stocks news, Stocks on the move,